Company Data

Enlivex Therapeutics Ltd.

Ticker
ENLV
Current Price
$0.99501 2.05%
Market Cap
$23.7M
Price Target
Refer to Report
Volume
68.4K
52wk Range
$0.8101 - $1.76
Advanced Market Data

Overview

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company’s Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system’s own natural regulation mechanisms.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy